Does DUPILUMAB Cause Injection site hypersensitivity? 125 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Injection site hypersensitivity have been filed in association with DUPILUMAB (Dupixent). This represents 0.0% of all adverse event reports for DUPILUMAB.
125
Reports of Injection site hypersensitivity with DUPILUMAB
0.0%
of all DUPILUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Injection site hypersensitivity From DUPILUMAB?
Of the 125 reports, 2 (1.6%) required hospitalization.
Is Injection site hypersensitivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 125 reports have been filed with the FAERS database.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Injection site hypersensitivity?
ETANERCEPT (363)
TIRZEPATIDE (333)
ADALIMUMAB (295)
TOCILIZUMAB (103)
METHOTREXATE (82)
DULAGLUTIDE (73)
IXEKIZUMAB (71)
OCTREOTIDE (67)
ANAKINRA (60)
GLATIRAMER (60)
Which DUPILUMAB Alternatives Have Lower Injection site hypersensitivity Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE